Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) EBIT (2016 - 2026)

InflaRx's EBIT history spans 9 years, with the latest figure at -$8.4 million for Q1 2026.

  • On a quarterly basis, EBIT rose 38.31% to -$8.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.1 million, a 870.36% increase, with the full-year FY2025 number at -$56.18, up 0.83% from a year prior.
  • EBIT hit -$8.4 million in Q1 2026 for InflaRx, down from $41.2 million in the prior quarter.
  • Over the last five years, EBIT for IFRX hit a ceiling of $46.2 million in Q4 2024 and a floor of -$16.9 million in Q3 2024.
  • Historically, EBIT has averaged -$4.1 million across 5 years, with a median of -$11.1 million in 2025.
  • Biggest five-year swings in EBIT: plummeted 140083597.94% in 2023 and later soared 422.78% in 2024.
  • Tracing IFRX's EBIT over 5 years: stood at -$7.9 million in 2022, then plummeted by 82.27% to -$14.3 million in 2023, then skyrocketed by 422.78% to $46.2 million in 2024, then dropped by 10.83% to $41.2 million in 2025, then tumbled by 120.48% to -$8.4 million in 2026.
  • Business Quant data shows EBIT for IFRX at -$8.4 million in Q1 2026, $41.2 million in Q4 2025, and -$11.1 million in Q3 2025.